J. Goldman & CO LP Vera Therapeutics, Inc. Transaction History
J. Goldman & CO LP
- $3.27 Billion
- Q2 2024
A detailed history of J. Goldman & CO LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 6,800 shares of VERA stock, worth $295,392. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,800
Previous 30,181
77.47%
Holding current value
$295,392
Previous $1.3 Million
81.09%
% of portfolio
0.01%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
182Shares Held
54.7MCall Options Held
42.2KPut Options Held
121K-
Avoro Capital Advisors LLC New York, NY4.31MShares$187 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$157 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$145 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$129 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$121 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.17B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...